GovChime
Awarded

6505--Levothyroxine Tablets XLCare Pharmaceuticals, Inc. Base Year Ordering Period: 1/27/2025 - 1/26/2026

Awarded tounder 36E79725D0004 (source: SAM.gov award notice)• $40.1M

Overview

Posted
November 27, 2024
Notice type
Award Notice

Notice details

Last updated
Jan 23, 2026
Award date
Nov 27, 2024
Award amount (SAM.gov award notice)
$40.1M

Identifiers

Solicitation number
36E79724R0020
Notice ID
ce7162f7079b4c9cb52b4d2a30284850
Award number (PIID)
36E79725D0004

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0020 for an unrestricted procurement for Levothyroxine Sodium (NA) Tablets for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s respective Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line Items 1-12, 90 count bottles/blisterpacks), must contain a child proof closure (safety cap) and a bottle with a minimum required size of 100cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Glass bottles are not acceptable. Product Samples. Offerors shall provide one sample (bottle/blisterpacks) for line item 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12. Samples will not be returned. (See FAR Clause 52.212-1(d)). Offerors shall provide a tracking number via email (to Youlanda.Duggar@va.gov) as soon as it s available. If samples are shipped directly from the manufacturer, please provide the name of the offeror with the samples. Samples shall consist of the empty proposed package (bottle or blister pack) and proposed label for all line items covered by this solicitation. Please do not include the actual drugs in the submitted samples. Solicitation # 36E79724R0020 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 16, 2024 with a tentative closing date of September 30, 2024 The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar Questions can be e-mailed to Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: Item Description PKG SIZE TOTAL EST ANNUAL (Tablets per Bottle or Blister Pack) USAGE (Bottles or Blister Packs) 1. LEVOTHYROXINE NA 100MCG TAB 90s 200,725 2. LEVOTHYROXINE NA 112MCG TAB 90s 134,235 3. LEVOTHYROXINE NA 125MCG TAB 90s 155,957 4. LEVOTHYROXINE NA 137MCG TAB 90s 89,375 5. LEVOTHYROXINE NA 150MCG TAB 90s 120,876 6. LEVOTHYROXINE NA 175MCG TAB 90s 78,193 7. LEVOTHYROXINE NA 200MCG TAB 90s 52,583 8. LEVOTHYROXINE NA 25MCG TAB 90s 184,129 9. LEVOTHYROXINE NA 300MCG TAB 90s 3,648 10. LEVOTHYROXINE NA 50MCG TAB 90s 282,262 11. LEVOTHYROXINE NA 75MCG TAB 90s 230,884 12. LEVOTHYROXINE NA 88MCG TAB 90s 139,816

Full description on SAM.gov

Award Overview

Award Number

36E79725D0004

Award Amount (SAM.gov award notice)

$40.1M

Award Date

Nov 27, 2024

Awardee

Awardee UEI

MEAUS5WHBJJ7

Original Solicitation

Notice ID: ce7162f7079b4c9cb52b4d2a30284850

Posted Date: Nov 27, 2024

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36F79726D0120
    XLCARE PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 13, 2026
  • 36F79726D0120
    XLCARE PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 4, 2026
  • 36F79726D0120
    XLCARE PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 3, 2026
  • 36F79726D0120
    XLCARE PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 30, 2026
  • 36F79726D0120
    XLCARE PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 29, 2026

Contacts

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Award NoticeDepartment of Veterans AffairsNov 27, 2024-

Lifecycle

Solicitation:36E79724R0020
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationAug 27, 2024

    6505--Levothyroxine Tablets (VA-24-00084562)

    Notice 50f1f58787904a6d98d166173ee79935 on SAM.gov

  2. SolicitationSep 16, 2024

    6505--Levothyroxine Tablets (VA-24-00084562)

    Notice e6a814ab06ae460dbb42e7e9d9c3b52c on SAM.gov

  3. AwardedCurrentNov 27, 2024

    6505--Levothyroxine Tablets XLCare Pharmaceuticals, Inc. Base Year Ordering Period: 1/27/2025 - 1/26/2026

    Notice ce7162f7079b4c9cb52b4d2a30284850 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36E79724R0020

Archive Date

Jan 26, 2025

Office Address

HINES, IL, 60141